Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK Cell Changes with Peg-IFN-α-2a vs Nucleoside Analogues in Chronic Hepatitis B
NCT03208998Phase 4Unknown
- Sponsor
- Beijing Ditan Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Beijing Ditan Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03208998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208998.